| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Smoking Cessation | 26 | 2025 | 590 | 2.800 |
Why?
|
| Military Personnel | 14 | 2024 | 110 | 1.740 |
Why?
|
| Tobacco Use Disorder | 11 | 2022 | 250 | 1.400 |
Why?
|
| Humans | 180 | 2026 | 43102 | 1.320 |
Why?
|
| Female | 135 | 2025 | 24698 | 1.300 |
Why?
|
| Adult | 94 | 2025 | 13872 | 1.240 |
Why?
|
| Overweight | 13 | 2024 | 249 | 1.220 |
Why?
|
| Obesity | 25 | 2024 | 1151 | 1.130 |
Why?
|
| Young Adult | 55 | 2025 | 5080 | 1.110 |
Why?
|
| Adolescent | 54 | 2025 | 6081 | 1.030 |
Why?
|
| Smoking | 16 | 2021 | 1024 | 1.020 |
Why?
|
| Pregnancy Complications | 7 | 2024 | 140 | 1.020 |
Why?
|
| Male | 105 | 2025 | 23409 | 1.000 |
Why?
|
| Weight Loss | 14 | 2024 | 137 | 0.970 |
Why?
|
| Logistic Models | 14 | 2021 | 1009 | 0.950 |
Why?
|
| Diabetes, Gestational | 3 | 2023 | 56 | 0.900 |
Why?
|
| United States | 47 | 2025 | 5205 | 0.850 |
Why?
|
| Cross-Sectional Studies | 37 | 2025 | 3156 | 0.810 |
Why?
|
| Cannabis | 2 | 2023 | 90 | 0.810 |
Why?
|
| Diabetes Mellitus, Type 2 | 12 | 2023 | 760 | 0.760 |
Why?
|
| Middle Aged | 63 | 2025 | 12222 | 0.750 |
Why?
|
| Veterans | 5 | 2019 | 210 | 0.730 |
Why?
|
| Pregnancy | 22 | 2024 | 1772 | 0.720 |
Why?
|
| Weight Gain | 11 | 2024 | 139 | 0.700 |
Why?
|
| Product Labeling | 4 | 2025 | 8 | 0.690 |
Why?
|
| Carcinoma, Ehrlich Tumor | 2 | 2011 | 20 | 0.680 |
Why?
|
| Arkansas | 25 | 2021 | 44 | 0.660 |
Why?
|
| Patient Education as Topic | 6 | 2021 | 235 | 0.620 |
Why?
|
| Prevalence | 20 | 2024 | 1612 | 0.610 |
Why?
|
| Directive Counseling | 2 | 2010 | 16 | 0.610 |
Why?
|
| Aged | 44 | 2024 | 8214 | 0.600 |
Why?
|
| Health Knowledge, Attitudes, Practice | 12 | 2022 | 989 | 0.600 |
Why?
|
| Body Mass Index | 18 | 2025 | 925 | 0.600 |
Why?
|
| Life Change Events | 1 | 2019 | 109 | 0.580 |
Why?
|
| Healthcare Disparities | 6 | 2025 | 590 | 0.570 |
Why?
|
| Adaptation, Psychological | 3 | 2020 | 420 | 0.540 |
Why?
|
| Pre-Eclampsia | 4 | 2023 | 67 | 0.530 |
Why?
|
| Adolescent Behavior | 6 | 2021 | 281 | 0.520 |
Why?
|
| Rural Population | 6 | 2022 | 373 | 0.520 |
Why?
|
| Premature Birth | 3 | 2023 | 95 | 0.510 |
Why?
|
| Alcohol Drinking | 5 | 2022 | 609 | 0.510 |
Why?
|
| Health Behavior | 11 | 2021 | 575 | 0.510 |
Why?
|
| Infant, Newborn | 11 | 2024 | 972 | 0.490 |
Why?
|
| Substance-Related Disorders | 6 | 2024 | 830 | 0.480 |
Why?
|
| Life Style | 7 | 2025 | 334 | 0.480 |
Why?
|
| Hotlines | 3 | 2017 | 16 | 0.480 |
Why?
|
| Florida | 11 | 2025 | 478 | 0.470 |
Why?
|
| Randomized Controlled Trials as Topic | 9 | 2025 | 375 | 0.470 |
Why?
|
| Marijuana Smoking | 3 | 2023 | 91 | 0.460 |
Why?
|
| Health Services Accessibility | 4 | 2019 | 706 | 0.450 |
Why?
|
| Risk Factors | 25 | 2025 | 3994 | 0.450 |
Why?
|
| Mass Screening | 8 | 2018 | 541 | 0.430 |
Why?
|
| Apolipoprotein E4 | 2 | 2025 | 67 | 0.420 |
Why?
|
| HIV Infections | 6 | 2025 | 2586 | 0.410 |
Why?
|
| Vaccination | 3 | 2025 | 355 | 0.410 |
Why?
|
| Preventive Health Services | 2 | 2018 | 66 | 0.410 |
Why?
|
| Cognition | 3 | 2025 | 473 | 0.410 |
Why?
|
| Dysphonia | 3 | 2020 | 5 | 0.410 |
Why?
|
| Students | 6 | 2025 | 626 | 0.400 |
Why?
|
| Hepatitis C | 2 | 2025 | 139 | 0.400 |
Why?
|
| Models, Theoretical | 2 | 2011 | 232 | 0.390 |
Why?
|
| Amputees | 2 | 2023 | 12 | 0.390 |
Why?
|
| Artificial Limbs | 2 | 2023 | 12 | 0.390 |
Why?
|
| Diabetes Mellitus | 6 | 2020 | 539 | 0.370 |
Why?
|
| Self Efficacy | 4 | 2022 | 215 | 0.370 |
Why?
|
| Analgesics, Opioid | 3 | 2021 | 252 | 0.370 |
Why?
|
| Indians, North American | 3 | 2005 | 192 | 0.360 |
Why?
|
| Secondary Prevention | 2 | 2010 | 48 | 0.360 |
Why?
|
| Cross-Over Studies | 4 | 2025 | 115 | 0.360 |
Why?
|
| Exercise | 7 | 2025 | 692 | 0.350 |
Why?
|
| Combined Modality Therapy | 2 | 2017 | 173 | 0.350 |
Why?
|
| Patient Acceptance of Health Care | 7 | 2019 | 497 | 0.350 |
Why?
|
| Nicotine | 5 | 2024 | 302 | 0.340 |
Why?
|
| Iodoacetates | 1 | 2010 | 2 | 0.340 |
Why?
|
| Community-Based Participatory Research | 6 | 2019 | 352 | 0.340 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2010 | 15 | 0.330 |
Why?
|
| Homeodomain Proteins | 1 | 2011 | 150 | 0.330 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 2 | 2022 | 20 | 0.330 |
Why?
|
| Practice Guidelines as Topic | 2 | 2009 | 223 | 0.330 |
Why?
|
| Myocardial Infarction | 4 | 2021 | 247 | 0.330 |
Why?
|
| Early Detection of Cancer | 4 | 2018 | 449 | 0.320 |
Why?
|
| Body Weight | 5 | 2024 | 429 | 0.320 |
Why?
|
| Public Health | 3 | 2026 | 424 | 0.320 |
Why?
|
| Health Policy | 5 | 2021 | 184 | 0.320 |
Why?
|
| Health Surveys | 8 | 2024 | 405 | 0.320 |
Why?
|
| Advisory Committees | 2 | 2019 | 35 | 0.320 |
Why?
|
| Socioeconomic Factors | 13 | 2025 | 1234 | 0.310 |
Why?
|
| Acculturation | 2 | 2022 | 205 | 0.300 |
Why?
|
| Carotid Artery, Common | 4 | 2013 | 9 | 0.300 |
Why?
|
| Uterine Cervical Neoplasms | 5 | 2012 | 367 | 0.290 |
Why?
|
| Retrospective Studies | 13 | 2024 | 2544 | 0.290 |
Why?
|
| Longitudinal Studies | 9 | 2026 | 1063 | 0.290 |
Why?
|
| Colorectal Neoplasms | 4 | 2018 | 512 | 0.290 |
Why?
|
| Gene Expression | 1 | 2011 | 701 | 0.290 |
Why?
|
| Birth Weight | 4 | 2022 | 95 | 0.280 |
Why?
|
| Health Education | 7 | 2015 | 363 | 0.280 |
Why?
|
| Postpartum Period | 3 | 2024 | 92 | 0.280 |
Why?
|
| Depression | 2 | 2025 | 863 | 0.270 |
Why?
|
| Child | 13 | 2025 | 3443 | 0.260 |
Why?
|
| Bone Density | 2 | 2025 | 103 | 0.250 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2008 | 126 | 0.250 |
Why?
|
| Cohort Studies | 9 | 2020 | 1759 | 0.250 |
Why?
|
| Gestational Age | 3 | 2022 | 200 | 0.250 |
Why?
|
| Marijuana Abuse | 1 | 2008 | 100 | 0.250 |
Why?
|
| Hypertension | 5 | 2021 | 835 | 0.250 |
Why?
|
| Body Water | 2 | 2023 | 26 | 0.250 |
Why?
|
| Family Planning Services | 3 | 2012 | 34 | 0.250 |
Why?
|
| Schools | 5 | 2020 | 283 | 0.250 |
Why?
|
| Drinking | 2 | 2023 | 37 | 0.240 |
Why?
|
| Opioid-Related Disorders | 2 | 2019 | 195 | 0.240 |
Why?
|
| Models, Biological | 2 | 2010 | 712 | 0.240 |
Why?
|
| Religion | 2 | 2018 | 90 | 0.240 |
Why?
|
| Body Composition | 2 | 2025 | 159 | 0.240 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2020 | 53 | 0.240 |
Why?
|
| Infant | 4 | 2022 | 1175 | 0.230 |
Why?
|
| Ultrasonography, Prenatal | 3 | 2020 | 40 | 0.230 |
Why?
|
| Breast Neoplasms | 6 | 2017 | 1723 | 0.230 |
Why?
|
| Poliomyelitis | 1 | 2005 | 7 | 0.230 |
Why?
|
| Receptors, GABA | 1 | 2025 | 28 | 0.230 |
Why?
|
| Spheroids, Cellular | 1 | 2005 | 37 | 0.220 |
Why?
|
| Intention | 2 | 2024 | 108 | 0.220 |
Why?
|
| Environmental Exposure | 3 | 2020 | 256 | 0.220 |
Why?
|
| Aged, 80 and over | 9 | 2023 | 2853 | 0.220 |
Why?
|
| Models, Statistical | 1 | 2026 | 195 | 0.220 |
Why?
|
| Referral and Consultation | 3 | 2010 | 142 | 0.220 |
Why?
|
| Health Status | 3 | 2014 | 442 | 0.220 |
Why?
|
| Cardiovascular Diseases | 3 | 2023 | 749 | 0.220 |
Why?
|
| Skin | 3 | 2012 | 187 | 0.220 |
Why?
|
| Comparative Effectiveness Research | 3 | 2019 | 16 | 0.220 |
Why?
|
| Emergency Service, Hospital | 2 | 2018 | 278 | 0.210 |
Why?
|
| Workplace | 1 | 2025 | 92 | 0.210 |
Why?
|
| Soil Pollutants | 3 | 2012 | 105 | 0.210 |
Why?
|
| Patient Preference | 1 | 2024 | 60 | 0.210 |
Why?
|
| Epilepsy | 1 | 2024 | 59 | 0.210 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2010 | 89 | 0.210 |
Why?
|
| Perception | 4 | 2018 | 215 | 0.210 |
Why?
|
| Atherosclerosis | 1 | 2006 | 169 | 0.210 |
Why?
|
| Patient Compliance | 6 | 2012 | 233 | 0.210 |
Why?
|
| Healthy People Programs | 1 | 2003 | 25 | 0.210 |
Why?
|
| Vulnerable Populations | 1 | 2025 | 166 | 0.200 |
Why?
|
| Uterine Rupture | 1 | 2023 | 5 | 0.200 |
Why?
|
| Diet | 4 | 2025 | 826 | 0.200 |
Why?
|
| Stroke | 2 | 2021 | 340 | 0.200 |
Why?
|
| Apolipoproteins E | 1 | 2024 | 138 | 0.200 |
Why?
|
| Pilot Projects | 7 | 2024 | 760 | 0.200 |
Why?
|
| Microglia | 1 | 2025 | 208 | 0.200 |
Why?
|
| Telephone | 4 | 2022 | 36 | 0.200 |
Why?
|
| Information Dissemination | 2 | 2021 | 66 | 0.190 |
Why?
|
| Employment | 2 | 2022 | 86 | 0.190 |
Why?
|
| Lebanon | 4 | 2024 | 21 | 0.190 |
Why?
|
| Minority Groups | 2 | 2025 | 690 | 0.190 |
Why?
|
| Stress, Psychological | 3 | 2022 | 661 | 0.190 |
Why?
|
| Counseling | 3 | 2020 | 138 | 0.190 |
Why?
|
| Child Abuse | 1 | 2023 | 92 | 0.180 |
Why?
|
| Fetal Macrosomia | 1 | 2021 | 12 | 0.180 |
Why?
|
| Neoplasms | 2 | 2010 | 1377 | 0.180 |
Why?
|
| Self Care | 4 | 2021 | 175 | 0.180 |
Why?
|
| Medicaid | 3 | 2020 | 143 | 0.180 |
Why?
|
| Administrative Personnel | 1 | 2021 | 11 | 0.170 |
Why?
|
| Sleep | 2 | 2025 | 185 | 0.170 |
Why?
|
| Risk Assessment | 7 | 2020 | 863 | 0.170 |
Why?
|
| Follow-Up Studies | 10 | 2018 | 1067 | 0.170 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2021 | 14 | 0.170 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2021 | 26 | 0.170 |
Why?
|
| Ambulatory Care | 2 | 2019 | 81 | 0.170 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2021 | 22 | 0.170 |
Why?
|
| Lead Poisoning, Nervous System | 1 | 2020 | 5 | 0.170 |
Why?
|
| Multivariate Analysis | 2 | 2021 | 638 | 0.170 |
Why?
|
| Research Design | 4 | 2017 | 385 | 0.170 |
Why?
|
| Fetal Weight | 1 | 2020 | 9 | 0.170 |
Why?
|
| Meditation | 1 | 2021 | 25 | 0.170 |
Why?
|
| Yoga | 1 | 2021 | 33 | 0.170 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2020 | 22 | 0.170 |
Why?
|
| Prospective Studies | 6 | 2022 | 1600 | 0.170 |
Why?
|
| Biomedical Research | 1 | 2026 | 502 | 0.170 |
Why?
|
| Food Services | 2 | 2011 | 33 | 0.160 |
Why?
|
| Receptors, Opioid, mu | 1 | 2020 | 52 | 0.160 |
Why?
|
| Brain Chemistry | 1 | 2020 | 141 | 0.160 |
Why?
|
| Nutrition Policy | 2 | 2011 | 64 | 0.160 |
Why?
|
| Reminder Systems | 2 | 2018 | 16 | 0.160 |
Why?
|
| Behavior Therapy | 2 | 2012 | 180 | 0.160 |
Why?
|
| Yolk Sac | 1 | 2020 | 4 | 0.160 |
Why?
|
| Drug Monitoring | 2 | 2018 | 69 | 0.160 |
Why?
|
| Delivery, Obstetric | 1 | 2020 | 48 | 0.160 |
Why?
|
| Voice Training | 1 | 2019 | 1 | 0.160 |
Why?
|
| Treatment Outcome | 9 | 2021 | 1604 | 0.160 |
Why?
|
| Transients and Migrants | 1 | 2020 | 42 | 0.160 |
Why?
|
| Tooth Extraction | 1 | 2019 | 5 | 0.160 |
Why?
|
| Primary Health Care | 2 | 2016 | 380 | 0.160 |
Why?
|
| Calcium, Dietary | 1 | 2020 | 65 | 0.160 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2019 | 14 | 0.160 |
Why?
|
| Contraception Behavior | 1 | 2020 | 33 | 0.150 |
Why?
|
| Abortion, Spontaneous | 1 | 2020 | 27 | 0.150 |
Why?
|
| Brain | 2 | 2025 | 1472 | 0.150 |
Why?
|
| Flavoring Agents | 1 | 2019 | 22 | 0.150 |
Why?
|
| Social Support | 2 | 2019 | 445 | 0.150 |
Why?
|
| Health Services Needs and Demand | 2 | 2019 | 154 | 0.150 |
Why?
|
| Culture | 2 | 2018 | 172 | 0.150 |
Why?
|
| Physicians | 2 | 2019 | 188 | 0.150 |
Why?
|
| Floors and Floorcoverings | 2 | 2009 | 3 | 0.150 |
Why?
|
| Age Distribution | 7 | 2021 | 249 | 0.150 |
Why?
|
| Diet Therapy | 1 | 2018 | 5 | 0.150 |
Why?
|
| Pulmonary Artery | 1 | 2018 | 32 | 0.150 |
Why?
|
| Zea mays | 1 | 2020 | 76 | 0.140 |
Why?
|
| Uterine Artery | 1 | 2018 | 2 | 0.140 |
Why?
|
| Databases, Factual | 4 | 2015 | 341 | 0.140 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2018 | 45 | 0.140 |
Why?
|
| Blood Pressure | 2 | 2021 | 666 | 0.140 |
Why?
|
| Developmental Disabilities | 1 | 2019 | 67 | 0.140 |
Why?
|
| Fees, Pharmaceutical | 1 | 2018 | 3 | 0.140 |
Why?
|
| Blood Flow Velocity | 1 | 2018 | 87 | 0.140 |
Why?
|
| Motivation | 4 | 2025 | 513 | 0.140 |
Why?
|
| Mandatory Programs | 1 | 2018 | 5 | 0.140 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2021 | 193 | 0.140 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2018 | 27 | 0.140 |
Why?
|
| Health Promotion | 5 | 2022 | 704 | 0.140 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2020 | 174 | 0.140 |
Why?
|
| Chronic Disease | 2 | 2018 | 549 | 0.140 |
Why?
|
| Needs Assessment | 1 | 2019 | 178 | 0.140 |
Why?
|
| Fetal Heart | 1 | 2017 | 4 | 0.140 |
Why?
|
| Population Surveillance | 3 | 2012 | 246 | 0.130 |
Why?
|
| Fetal Development | 1 | 2017 | 34 | 0.130 |
Why?
|
| Interviews as Topic | 4 | 2008 | 452 | 0.130 |
Why?
|
| Alzheimer Disease | 1 | 2025 | 1001 | 0.130 |
Why?
|
| Insurance Coverage | 1 | 2018 | 110 | 0.130 |
Why?
|
| Health Status Disparities | 3 | 2013 | 719 | 0.130 |
Why?
|
| Soil | 2 | 2009 | 171 | 0.130 |
Why?
|
| Cooperative Behavior | 2 | 2016 | 269 | 0.130 |
Why?
|
| Food Supply | 1 | 2018 | 122 | 0.130 |
Why?
|
| Immunization Schedule | 1 | 2016 | 9 | 0.130 |
Why?
|
| Feeding Behavior | 2 | 2018 | 469 | 0.130 |
Why?
|
| Carotid Artery Diseases | 2 | 2008 | 26 | 0.130 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2016 | 4 | 0.130 |
Why?
|
| Tobacco Industry | 1 | 2016 | 9 | 0.120 |
Why?
|
| Preoperative Care | 1 | 2016 | 32 | 0.120 |
Why?
|
| Oklahoma | 4 | 2005 | 28 | 0.120 |
Why?
|
| Immunization | 1 | 2016 | 94 | 0.120 |
Why?
|
| Voice Quality | 2 | 2019 | 5 | 0.120 |
Why?
|
| Ultrasonography | 5 | 2008 | 135 | 0.120 |
Why?
|
| Community Health Services | 3 | 2012 | 206 | 0.120 |
Why?
|
| Length of Stay | 2 | 2015 | 229 | 0.120 |
Why?
|
| Blood Glucose | 3 | 2019 | 389 | 0.120 |
Why?
|
| Incidence | 6 | 2020 | 1078 | 0.120 |
Why?
|
| Dextropropoxyphene | 1 | 2015 | 1 | 0.120 |
Why?
|
| Safety-Based Drug Withdrawals | 1 | 2015 | 1 | 0.120 |
Why?
|
| Proportional Hazards Models | 3 | 2020 | 518 | 0.120 |
Why?
|
| Urban Population | 1 | 2017 | 374 | 0.110 |
Why?
|
| Ethanol | 1 | 2017 | 224 | 0.110 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2013 | 58 | 0.110 |
Why?
|
| Universities | 4 | 2025 | 559 | 0.110 |
Why?
|
| Data Collection | 3 | 2015 | 210 | 0.110 |
Why?
|
| Program Development | 2 | 2013 | 240 | 0.110 |
Why?
|
| Evidence-Based Medicine | 2 | 2011 | 107 | 0.110 |
Why?
|
| Beverages | 2 | 2023 | 66 | 0.110 |
Why?
|
| Patient Discharge | 1 | 2015 | 128 | 0.100 |
Why?
|
| Family | 1 | 2015 | 195 | 0.100 |
Why?
|
| Cell Proliferation | 3 | 2010 | 1455 | 0.100 |
Why?
|
| Survival Analysis | 3 | 2026 | 368 | 0.100 |
Why?
|
| Urinary Catheterization | 1 | 2013 | 4 | 0.100 |
Why?
|
| Catheters, Indwelling | 1 | 2013 | 10 | 0.100 |
Why?
|
| Quality of Health Care | 1 | 2015 | 161 | 0.100 |
Why?
|
| Safety | 1 | 2014 | 54 | 0.100 |
Why?
|
| Urinary Incontinence | 1 | 2013 | 15 | 0.100 |
Why?
|
| Program Evaluation | 5 | 2012 | 359 | 0.100 |
Why?
|
| Time and Motion Studies | 2 | 2023 | 13 | 0.100 |
Why?
|
| Housing | 1 | 2014 | 74 | 0.100 |
Why?
|
| Patient Readmission | 1 | 2015 | 122 | 0.100 |
Why?
|
| Quality of Life | 3 | 2023 | 616 | 0.100 |
Why?
|
| Time Factors | 5 | 2019 | 1857 | 0.100 |
Why?
|
| Long-Term Care | 1 | 2013 | 55 | 0.100 |
Why?
|
| Health Services for the Aged | 1 | 2012 | 26 | 0.100 |
Why?
|
| Aluminum | 2 | 2012 | 39 | 0.100 |
Why?
|
| Prenatal Care | 2 | 2024 | 93 | 0.100 |
Why?
|
| Postural Balance | 2 | 2023 | 37 | 0.100 |
Why?
|
| Lower Extremity | 2 | 2023 | 38 | 0.100 |
Why?
|
| Carbon Monoxide | 2 | 2025 | 47 | 0.090 |
Why?
|
| Behavioral Risk Factor Surveillance System | 2 | 2022 | 82 | 0.090 |
Why?
|
| Predictive Value of Tests | 4 | 2020 | 440 | 0.090 |
Why?
|
| Proton Pump Inhibitors | 1 | 2012 | 16 | 0.090 |
Why?
|
| Rural Health Services | 1 | 2012 | 48 | 0.090 |
Why?
|
| Ticlopidine | 1 | 2012 | 17 | 0.090 |
Why?
|
| Echocardiography | 1 | 2013 | 167 | 0.090 |
Why?
|
| After-Hours Care | 1 | 2012 | 4 | 0.090 |
Why?
|
| Alcoholism | 1 | 2016 | 305 | 0.090 |
Why?
|
| Peer Group | 2 | 2016 | 177 | 0.090 |
Why?
|
| Dioxins | 1 | 2012 | 8 | 0.090 |
Why?
|
| Ceramics | 1 | 2012 | 6 | 0.090 |
Why?
|
| Aluminum Silicates | 1 | 2012 | 7 | 0.090 |
Why?
|
| Genotype | 2 | 2025 | 800 | 0.090 |
Why?
|
| Preconception Care | 1 | 2012 | 12 | 0.090 |
Why?
|
| Animals | 5 | 2025 | 16992 | 0.090 |
Why?
|
| Tobacco, Smokeless | 3 | 2016 | 19 | 0.090 |
Why?
|
| Mental Healing | 1 | 2011 | 2 | 0.090 |
Why?
|
| Patient Admission | 1 | 2012 | 50 | 0.090 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2012 | 77 | 0.090 |
Why?
|
| Continuity of Patient Care | 2 | 2010 | 120 | 0.090 |
Why?
|
| Child Behavior | 2 | 2009 | 81 | 0.090 |
Why?
|
| Feasibility Studies | 3 | 2021 | 259 | 0.090 |
Why?
|
| Prognosis | 3 | 2020 | 861 | 0.090 |
Why?
|
| Occupational Exposure | 1 | 2012 | 91 | 0.090 |
Why?
|
| Lead Poisoning | 1 | 2011 | 25 | 0.090 |
Why?
|
| Occupational Diseases | 1 | 2011 | 53 | 0.080 |
Why?
|
| Nutrition Assessment | 1 | 2011 | 80 | 0.080 |
Why?
|
| Viral Load | 2 | 2022 | 348 | 0.080 |
Why?
|
| Adult Stem Cells | 1 | 2010 | 12 | 0.080 |
Why?
|
| Speech Production Measurement | 1 | 2010 | 3 | 0.080 |
Why?
|
| Bupropion | 2 | 2023 | 13 | 0.080 |
Why?
|
| Age Factors | 4 | 2019 | 1154 | 0.080 |
Why?
|
| Atrial Fibrillation | 1 | 2012 | 122 | 0.080 |
Why?
|
| Disease Progression | 2 | 2010 | 667 | 0.080 |
Why?
|
| Hospital Mortality | 1 | 2012 | 210 | 0.080 |
Why?
|
| Refractive Errors | 1 | 2010 | 28 | 0.080 |
Why?
|
| Interpersonal Relations | 1 | 2012 | 222 | 0.080 |
Why?
|
| Administration, Cutaneous | 1 | 2010 | 48 | 0.080 |
Why?
|
| Internet | 1 | 2012 | 236 | 0.080 |
Why?
|
| Hospitals, Pediatric | 1 | 2010 | 22 | 0.080 |
Why?
|
| Embryonic Stem Cells | 1 | 2010 | 55 | 0.080 |
Why?
|
| Environmental Monitoring | 2 | 2009 | 230 | 0.080 |
Why?
|
| Cardiotonic Agents | 1 | 2010 | 40 | 0.080 |
Why?
|
| Drug Prescriptions | 1 | 2010 | 60 | 0.080 |
Why?
|
| Pregnancy Outcome | 2 | 2020 | 102 | 0.080 |
Why?
|
| Nicotinic Agonists | 1 | 2010 | 88 | 0.080 |
Why?
|
| Odds Ratio | 4 | 2013 | 587 | 0.080 |
Why?
|
| Legislation, Hospital | 1 | 2009 | 1 | 0.080 |
Why?
|
| Emigrants and Immigrants | 1 | 2011 | 158 | 0.070 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2009 | 43 | 0.070 |
Why?
|
| Intelligence | 1 | 2009 | 15 | 0.070 |
Why?
|
| Agonistic Behavior | 1 | 2008 | 2 | 0.070 |
Why?
|
| Tunica Media | 2 | 2008 | 15 | 0.070 |
Why?
|
| Tunica Intima | 2 | 2008 | 22 | 0.070 |
Why?
|
| Diverticulosis, Colonic | 1 | 2008 | 3 | 0.070 |
Why?
|
| Hernia, Hiatal | 1 | 2008 | 7 | 0.070 |
Why?
|
| Gallbladder Diseases | 1 | 2008 | 6 | 0.070 |
Why?
|
| Stereotyping | 1 | 2009 | 45 | 0.070 |
Why?
|
| Communication | 2 | 2021 | 210 | 0.070 |
Why?
|
| Tennessee | 2 | 2020 | 93 | 0.070 |
Why?
|
| Poverty | 1 | 2012 | 400 | 0.070 |
Why?
|
| Severity of Illness Index | 2 | 2008 | 719 | 0.070 |
Why?
|
| Sensitivity and Specificity | 3 | 2018 | 611 | 0.070 |
Why?
|
| Prejudice | 1 | 2009 | 116 | 0.070 |
Why?
|
| Sex Factors | 4 | 2017 | 1028 | 0.070 |
Why?
|
| Organizational Policy | 1 | 2007 | 25 | 0.070 |
Why?
|
| Recurrence | 2 | 2019 | 152 | 0.070 |
Why?
|
| Hospitals, University | 1 | 2007 | 39 | 0.070 |
Why?
|
| Guideline Adherence | 1 | 2008 | 98 | 0.070 |
Why?
|
| Acetaminophen | 2 | 2019 | 30 | 0.070 |
Why?
|
| Attitude to Health | 2 | 2007 | 338 | 0.070 |
Why?
|
| School Health Services | 1 | 2008 | 90 | 0.070 |
Why?
|
| Computer Simulation | 3 | 2021 | 408 | 0.070 |
Why?
|
| Algorithms | 1 | 2010 | 509 | 0.070 |
Why?
|
| Multiple Myeloma | 1 | 2007 | 48 | 0.070 |
Why?
|
| Motor Activity | 1 | 2010 | 437 | 0.060 |
Why?
|
| Dietary Sucrose | 1 | 2006 | 17 | 0.060 |
Why?
|
| Mice | 2 | 2025 | 6644 | 0.060 |
Why?
|
| Coronary Angiography | 1 | 2007 | 96 | 0.060 |
Why?
|
| Sex Distribution | 3 | 2016 | 224 | 0.060 |
Why?
|
| Heart Arrest | 1 | 2007 | 52 | 0.060 |
Why?
|
| Glioma | 1 | 2007 | 96 | 0.060 |
Why?
|
| Cultural Competency | 1 | 2008 | 138 | 0.060 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2006 | 2 | 0.060 |
Why?
|
| Clinical Competence | 1 | 2007 | 156 | 0.060 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2007 | 95 | 0.060 |
Why?
|
| Kidney Diseases | 1 | 2008 | 172 | 0.060 |
Why?
|
| Brain Neoplasms | 1 | 2007 | 140 | 0.060 |
Why?
|
| Inflammation Mediators | 1 | 2007 | 140 | 0.060 |
Why?
|
| Anger | 1 | 2025 | 27 | 0.060 |
Why?
|
| Attitude of Health Personnel | 1 | 2007 | 231 | 0.060 |
Why?
|
| Coronary Artery Disease | 1 | 2007 | 163 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2018 | 1285 | 0.060 |
Why?
|
| Morbidity | 2 | 2018 | 97 | 0.060 |
Why?
|
| Occult Blood | 2 | 2017 | 32 | 0.060 |
Why?
|
| Peru | 1 | 2024 | 41 | 0.050 |
Why?
|
| Arteriosclerosis | 1 | 2004 | 43 | 0.050 |
Why?
|
| Carotid Arteries | 1 | 2004 | 36 | 0.050 |
Why?
|
| Lumbar Vertebrae | 1 | 2025 | 44 | 0.050 |
Why?
|
| Organ Size | 2 | 2020 | 170 | 0.050 |
Why?
|
| Heterozygote | 1 | 2024 | 110 | 0.050 |
Why?
|
| Models, Cardiovascular | 1 | 2004 | 98 | 0.050 |
Why?
|
| Child, Preschool | 3 | 2019 | 1546 | 0.050 |
Why?
|
| Parents | 1 | 2008 | 370 | 0.050 |
Why?
|
| Hepacivirus | 1 | 2024 | 74 | 0.050 |
Why?
|
| Self Concept | 1 | 2025 | 171 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 1 | 2005 | 508 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2013 | 1081 | 0.050 |
Why?
|
| ROC Curve | 2 | 2018 | 159 | 0.050 |
Why?
|
| Drug Users | 1 | 2024 | 52 | 0.050 |
Why?
|
| Family Characteristics | 1 | 2024 | 126 | 0.050 |
Why?
|
| Hysterectomy | 1 | 2023 | 38 | 0.050 |
Why?
|
| Regression Analysis | 3 | 2012 | 490 | 0.050 |
Why?
|
| Texas | 1 | 2025 | 457 | 0.050 |
Why?
|
| Urinalysis | 1 | 2023 | 34 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 2676 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2025 | 665 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2023 | 126 | 0.050 |
Why?
|
| HIV Seropositivity | 1 | 2024 | 196 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2025 | 536 | 0.050 |
Why?
|
| India | 1 | 2022 | 108 | 0.050 |
Why?
|
| Analysis of Variance | 2 | 2018 | 575 | 0.050 |
Why?
|
| Educational Status | 3 | 2009 | 339 | 0.050 |
Why?
|
| Infant, Low Birth Weight | 1 | 2022 | 36 | 0.050 |
Why?
|
| New York | 2 | 2011 | 93 | 0.040 |
Why?
|
| Vital Signs | 1 | 2021 | 1 | 0.040 |
Why?
|
| Sexual Partners | 1 | 2024 | 326 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2023 | 258 | 0.040 |
Why?
|
| Mammography | 1 | 2002 | 212 | 0.040 |
Why?
|
| Iran | 1 | 2021 | 202 | 0.040 |
Why?
|
| Mitral Valve | 1 | 2021 | 36 | 0.040 |
Why?
|
| Alabama | 2 | 2012 | 52 | 0.040 |
Why?
|
| Confidence Intervals | 2 | 2013 | 162 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2020 | 11 | 0.040 |
Why?
|
| Rats, Long-Evans | 1 | 2020 | 108 | 0.040 |
Why?
|
| Water | 1 | 2023 | 316 | 0.040 |
Why?
|
| Health Care Surveys | 2 | 2012 | 152 | 0.040 |
Why?
|
| Inpatients | 1 | 2021 | 78 | 0.040 |
Why?
|
| Risk-Taking | 1 | 2003 | 457 | 0.040 |
Why?
|
| Behavior, Addictive | 1 | 2020 | 37 | 0.040 |
Why?
|
| Aging | 1 | 2006 | 783 | 0.040 |
Why?
|
| Hospitals | 1 | 2021 | 117 | 0.040 |
Why?
|
| Absorptiometry, Photon | 1 | 2020 | 76 | 0.040 |
Why?
|
| Pregnancy Trimester, First | 1 | 2020 | 20 | 0.040 |
Why?
|
| Muscle Tonus | 1 | 2019 | 6 | 0.040 |
Why?
|
| Ibuprofen | 1 | 2019 | 34 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2025 | 1596 | 0.040 |
Why?
|
| Lead | 1 | 2020 | 100 | 0.040 |
Why?
|
| Bone and Bones | 1 | 2020 | 114 | 0.040 |
Why?
|
| New York City | 2 | 2012 | 288 | 0.040 |
Why?
|
| Psychotherapy, Group | 1 | 2019 | 23 | 0.040 |
Why?
|
| Personal Satisfaction | 1 | 2019 | 76 | 0.040 |
Why?
|
| Contraception | 1 | 2020 | 60 | 0.040 |
Why?
|
| Narcotic Antagonists | 1 | 2019 | 78 | 0.040 |
Why?
|
| Homosexuality, Male | 1 | 2024 | 486 | 0.040 |
Why?
|
| Micronesia | 1 | 2019 | 90 | 0.040 |
Why?
|
| Skin Absorption | 2 | 2009 | 16 | 0.040 |
Why?
|
| Apgar Score | 1 | 2018 | 5 | 0.040 |
Why?
|
| Preventive Medicine | 1 | 2018 | 16 | 0.040 |
Why?
|
| Pulsatile Flow | 1 | 2018 | 28 | 0.040 |
Why?
|
| Dietary Supplements | 1 | 2020 | 213 | 0.040 |
Why?
|
| Coronary Artery Bypass | 2 | 2010 | 47 | 0.040 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2010 | 54 | 0.040 |
Why?
|
| Uterus | 1 | 2018 | 52 | 0.030 |
Why?
|
| Physical Fitness | 1 | 2018 | 90 | 0.030 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2010 | 78 | 0.030 |
Why?
|
| Diabetes Complications | 2 | 2009 | 102 | 0.030 |
Why?
|
| Umbilical Arteries | 1 | 2017 | 3 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 2017 | 7 | 0.030 |
Why?
|
| Papio | 1 | 2017 | 22 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2018 | 236 | 0.030 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2017 | 11 | 0.030 |
Why?
|
| Cerebral Arteries | 1 | 2017 | 24 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2018 | 185 | 0.030 |
Why?
|
| Fruit | 2 | 2011 | 178 | 0.030 |
Why?
|
| Southeastern United States | 1 | 2017 | 64 | 0.030 |
Why?
|
| Educational Measurement | 2 | 2009 | 102 | 0.030 |
Why?
|
| Rural Health | 1 | 2017 | 55 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2018 | 179 | 0.030 |
Why?
|
| Child Health Services | 1 | 2016 | 42 | 0.030 |
Why?
|
| Survival Rate | 1 | 2017 | 355 | 0.030 |
Why?
|
| Cause of Death | 1 | 2017 | 186 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 374 | 0.030 |
Why?
|
| Medication Adherence | 1 | 2018 | 182 | 0.030 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2015 | 33 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2021 | 1003 | 0.030 |
Why?
|
| Nutrition Surveys | 1 | 2016 | 263 | 0.030 |
Why?
|
| Social Environment | 1 | 2016 | 218 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 317 | 0.030 |
Why?
|
| Ventilation | 1 | 2014 | 4 | 0.030 |
Why?
|
| Sanitation | 1 | 2014 | 27 | 0.030 |
Why?
|
| Water Supply | 1 | 2014 | 60 | 0.030 |
Why?
|
| Anxiety | 1 | 2021 | 874 | 0.020 |
Why?
|
| Rats | 1 | 2020 | 3735 | 0.020 |
Why?
|
| Evidence-Based Practice | 1 | 2012 | 50 | 0.020 |
Why?
|
| Electric Countershock | 1 | 2012 | 12 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2012 | 207 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 2014 | 193 | 0.020 |
Why?
|
| Sigmoidoscopy | 1 | 2012 | 9 | 0.020 |
Why?
|
| Cotton Fiber | 1 | 2012 | 5 | 0.020 |
Why?
|
| Contraceptive Agents | 1 | 2012 | 13 | 0.020 |
Why?
|
| Computer Systems | 1 | 2012 | 19 | 0.020 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2012 | 13 | 0.020 |
Why?
|
| Hawaii | 1 | 2018 | 2011 | 0.020 |
Why?
|
| Acute Coronary Syndrome | 1 | 2012 | 42 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2012 | 150 | 0.020 |
Why?
|
| Health Educators | 1 | 2011 | 5 | 0.020 |
Why?
|
| Sex Education | 1 | 2012 | 36 | 0.020 |
Why?
|
| Menu Planning | 1 | 2011 | 8 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2012 | 284 | 0.020 |
Why?
|
| Diffusion of Innovation | 1 | 2011 | 38 | 0.020 |
Why?
|
| Facility Design and Construction | 1 | 2011 | 3 | 0.020 |
Why?
|
| Contract Services | 1 | 2011 | 2 | 0.020 |
Why?
|
| Paint | 1 | 2011 | 5 | 0.020 |
Why?
|
| Health Services | 1 | 2012 | 61 | 0.020 |
Why?
|
| Ownership | 1 | 2011 | 12 | 0.020 |
Why?
|
| Food Analysis | 1 | 2011 | 34 | 0.020 |
Why?
|
| Feces | 1 | 2012 | 132 | 0.020 |
Why?
|
| Women's Health Services | 1 | 2011 | 12 | 0.020 |
Why?
|
| Colonoscopy | 1 | 2012 | 122 | 0.020 |
Why?
|
| Urban Health | 1 | 2011 | 101 | 0.020 |
Why?
|
| Dust | 1 | 2011 | 57 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2012 | 148 | 0.020 |
Why?
|
| Observer Variation | 1 | 2010 | 59 | 0.020 |
Why?
|
| Consensus | 1 | 2010 | 48 | 0.020 |
Why?
|
| Telefacsimile | 1 | 2010 | 1 | 0.020 |
Why?
|
| Vegetables | 1 | 2011 | 147 | 0.020 |
Why?
|
| Food Dispensers, Automatic | 1 | 2010 | 4 | 0.020 |
Why?
|
| Hospitals, Veterans | 1 | 2010 | 15 | 0.020 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2010 | 72 | 0.020 |
Why?
|
| Carbonated Beverages | 1 | 2010 | 21 | 0.020 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2010 | 39 | 0.020 |
Why?
|
| Nutritive Value | 1 | 2010 | 37 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2011 | 165 | 0.020 |
Why?
|
| Comorbidity | 1 | 2012 | 737 | 0.020 |
Why?
|
| Vaginal Smears | 1 | 2009 | 63 | 0.020 |
Why?
|
| Adhesiveness | 1 | 2009 | 5 | 0.020 |
Why?
|
| Food Deprivation | 1 | 2009 | 33 | 0.020 |
Why?
|
| Cadaver | 1 | 2009 | 40 | 0.020 |
Why?
|
| Health Personnel | 1 | 2012 | 277 | 0.020 |
Why?
|
| Aspirin | 1 | 2010 | 89 | 0.020 |
Why?
|
| Fasting | 1 | 2009 | 56 | 0.020 |
Why?
|
| Aortic Aneurysm | 1 | 2008 | 5 | 0.020 |
Why?
|
| Environment | 1 | 2010 | 149 | 0.020 |
Why?
|
| Dyslipidemias | 1 | 2009 | 48 | 0.020 |
Why?
|
| Probability | 1 | 2008 | 82 | 0.020 |
Why?
|
| Hospitalization | 1 | 2012 | 485 | 0.020 |
Why?
|
| Policy Making | 1 | 2008 | 35 | 0.020 |
Why?
|
| Feedback, Psychological | 1 | 2008 | 16 | 0.020 |
Why?
|
| Creatinine | 1 | 2008 | 102 | 0.020 |
Why?
|
| Body Image | 1 | 2008 | 89 | 0.020 |
Why?
|
| Placebos | 1 | 2007 | 41 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 113 | 0.020 |
Why?
|
| Metformin | 1 | 2008 | 75 | 0.020 |
Why?
|
| Teaching | 1 | 2007 | 59 | 0.020 |
Why?
|
| Community Networks | 1 | 2008 | 107 | 0.020 |
Why?
|
| Coronary Stenosis | 1 | 2007 | 37 | 0.020 |
Why?
|
| Databases as Topic | 1 | 2006 | 25 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 2006 | 55 | 0.020 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2006 | 10 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2007 | 165 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2008 | 184 | 0.020 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2008 | 167 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2007 | 167 | 0.010 |
Why?
|
| Energy Intake | 1 | 2006 | 164 | 0.010 |
Why?
|
| Focus Groups | 1 | 2007 | 423 | 0.010 |
Why?
|
| Attention | 1 | 2007 | 174 | 0.010 |
Why?
|
| Epidemiologic Studies | 1 | 2005 | 33 | 0.010 |
Why?
|
| Cholesterol | 1 | 2006 | 232 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 384 | 0.010 |
Why?
|
| Vasodilation | 1 | 2004 | 64 | 0.010 |
Why?
|
| Income | 1 | 2005 | 160 | 0.010 |
Why?
|
| Cultural Diversity | 1 | 2005 | 193 | 0.010 |
Why?
|
| Insurance, Health | 1 | 2002 | 145 | 0.010 |
Why?
|